NM_021098.3:c.6652C>T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2

The NM_021098.3(CACNA1H):​c.6652C>T​(p.Arg2218Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000324 in 1,543,008 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2218H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000033 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

6
6
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.848

Publications

2 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6
Variant 16-1220584-C-T is Benign according to our data. Variant chr16-1220584-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 571712.
BS2
High AC in GnomAdExome4 at 46 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
NM_021098.3
MANE Select
c.6652C>Tp.Arg2218Cys
missense
Exon 35 of 35NP_066921.2
CACNA1H
NM_001005407.2
c.6634C>Tp.Arg2212Cys
missense
Exon 34 of 34NP_001005407.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
ENST00000348261.11
TSL:1 MANE Select
c.6652C>Tp.Arg2218Cys
missense
Exon 35 of 35ENSP00000334198.7
CACNA1H
ENST00000569107.6
TSL:1
c.6667C>Tp.Arg2223Cys
missense
Exon 34 of 34ENSP00000454990.2
CACNA1H
ENST00000711493.1
c.6637C>Tp.Arg2213Cys
missense
Exon 34 of 34ENSP00000518778.1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
151950
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000589
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000114
AC:
2
AN:
176190
AF XY:
0.0000206
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000120
Gnomad OTH exome
AF:
0.000243
GnomAD4 exome
AF:
0.0000331
AC:
46
AN:
1391058
Hom.:
0
Cov.:
35
AF XY:
0.0000306
AC XY:
21
AN XY:
686834
show subpopulations
African (AFR)
AF:
0.0000326
AC:
1
AN:
30650
American (AMR)
AF:
0.00
AC:
0
AN:
31286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21322
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39210
South Asian (SAS)
AF:
0.00
AC:
0
AN:
74264
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48002
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5414
European-Non Finnish (NFE)
AF:
0.0000388
AC:
42
AN:
1083718
Other (OTH)
AF:
0.0000525
AC:
3
AN:
57192
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.448
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
151950
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41366
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000589
AC:
4
AN:
67914
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.563
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000875
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.00000853
AC:
1

ClinVar

ClinVar submissions as Germline

Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV (1)
-
-
1
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV (1)
-
1
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.40
BayesDel_addAF
Benign
-0.041
T
BayesDel_noAF
Benign
-0.30
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.64
D
Eigen
Uncertain
0.24
Eigen_PC
Benign
0.14
FATHMM_MKL
Benign
0.65
D
LIST_S2
Uncertain
0.95
D
M_CAP
Pathogenic
0.69
D
MetaRNN
Uncertain
0.55
D
MetaSVM
Benign
-0.88
T
MutationAssessor
Pathogenic
3.0
M
PhyloP100
0.85
PrimateAI
Pathogenic
0.92
D
PROVEAN
Pathogenic
-5.7
D
REVEL
Benign
0.23
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.44
MutPred
0.32
Loss of solvent accessibility (P = 0.0079)
MVP
0.82
ClinPred
0.98
D
GERP RS
2.7
Varity_R
0.22
gMVP
0.26
Mutation Taster
=65/35
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs761083620; hg19: chr16-1270584; COSMIC: COSV52353706; COSMIC: COSV52353706; API